Literature DB >> 7919675

Protein synthesis in cancer patients with inflammatory response: investigations with [15N]glycine.

D C McMillan1, T Preston, K C Fearon, H J Burns, C Slater, A Shenkin.   

Abstract

It has been proposed that the increase in amino acid flux and derived protein synthesis rates observed in weight-losing cancer patients may contribute to an ongoing negative energy balance. The mediators and tissues responsible for such apparent increased protein synthesis have not been clearly identified. The aim of this study was to examine the relationship between protein synthetic rates in whole-body, skeletal muscle, and circulating cortisol concentrations in healthy subjects (n = 6) and cancer patients with evidence of an inflammatory response (n = 6). Protein synthetic rates were measured with a primed continuous 20-h infusion of [15N]glycine. Skeletal muscle was biopsied at laparotomy. Serum cortisol, resting energy expenditure, plasma proteins, nitrogen metabolites in urine, and skeletal muscle free amino acids were also measured. Derived whole-body and skeletal muscle protein synthetic rates in the cancer group were increased significantly (by 70 and 93%, respectively, p < 0.05). Circulating concentrations of cortisol, fibrinogen, and C-reactive protein were also significantly increased in the cancer group and indicated the presence of an inflammatory response. However, there was no significant increase in resting energy expenditure. Mechanisms by which apparent increases in whole-body and skeletal protein synthesis do not result in an increase in resting energy expenditure are discussed. We conclude that glycine utilization is increased in cancer patients but that rates of protein synthesis derived from [15N]glycine kinetics may not be valid in such patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7919675

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  7 in total

1.  Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response.

Authors:  K C Fearon; J S Falconer; C Slater; D C McMillan; J A Ross; T Preston
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

2.  The relationship between weight loss and interleukin 6 in non-small-cell lung cancer.

Authors:  H R Scott; D C McMillan; A Crilly; C S McArdle; R Milroy
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

3.  Prediction of clinical outcomes through assessment of sarcopenia and adipopenia using computed tomography in adult patients with acute myeloid leukemia.

Authors:  Jongheon Jung; Eunyoung Lee; Hyoeun Shim; Ju-Hyun Park; Hyeon-Seok Eom; Hyewon Lee
Journal:  Int J Hematol       Date:  2021-03-10       Impact factor: 2.490

Review 4.  Computational modeling of cancer cachexia.

Authors:  Kevin D Hall; Vickie E Baracos
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-05       Impact factor: 4.294

Review 5.  Regulation of muscle protein synthesis and the effects of catabolic states.

Authors:  Bradley S Gordon; Andrew R Kelleher; Scot R Kimball
Journal:  Int J Biochem Cell Biol       Date:  2013-06-12       Impact factor: 5.085

6.  Cancer cachexia: mechanisms and clinical implications.

Authors:  Claire L Donohoe; Aoife M Ryan; John V Reynolds
Journal:  Gastroenterol Res Pract       Date:  2011-06-13       Impact factor: 2.260

7.  The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.

Authors:  H R Scott; D C McMillan; L M Forrest; D J F Brown; C S McArdle; R Milroy
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.